Bioretec Ltd Managers' transactions
____________________________________________
Person subject to the notification requirement
Position: Member of the Board/Deputy member
Issuer:
LEI: 7437008736AG7HY51K13
Notification type: INITIAL NOTIFICATION
Reference number: 24301/5/6
____________________________________________
Transaction date: 2023-01-09
Outside a trading venue
Instrument type: FINANCIAL INSTRUMENT LINKED TO A SHARE OR A DEBT INSTRUMENT
ISIN: FI4000480454
Nature of the transaction: DISPOSAL
(X) Linked to stock option program
Transaction details
(1): Volume: 375000 Unit price:
Aggregated transactions (1):
Volume: 375000 Volume weighted average price:
Further inquiries
Certified Adviser:
Information about Bioretec
Bioretec is a globally operating Finnish medical device company that continues to pioneer the application of bioresorbable orthopedic implants. The company has built unique competencies in the biological interface of active implants to enhance bone growth and accelerate fracture healing after orthopedic surgery. The products developed and manufactured by Bioretec are used worldwide in approximately 40 countries.
Bioretec is developing the new RemeOs(TM) product line based on a magnesium alloy and hybrid composite, introducing a new generation of strong bioresorbable materials for enhanced surgical outcomes. The RemeOs(TM) implants are resorbed and replaced by bone, which eliminates the need for removal surgery while facilitating fracture healing. The combination has the potential to make titanium implants redundant and help clinics reach their
Better healing - Better life. www.bioretec.com
https://news.cision.com/bioretec/r/bioretec-ltd---managers--transactions,c3695386
(c) 2023 Cision. All rights reserved., source